ReviewTranslational lung cancer research2025
Chinese expert consensus on shape-sensing robotic-assisted bronchoscopy (ssRAB) in the management of peripheral pulmonary lesions.
Review in Translational lung cancer research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Annual progress in transbronchial diagnosis and treatment of pulmonary malignant tumors [2025]: a narrative review.Translational lung cancer research · 2026Review
- [Expert Consensus on Precision Management of Pulmonary Nodules (2026 Version)].Zhongguo fei ai za zhi = Chinese journal of lung cancer · 2026Article
- Robotic-assisted bronchoscopy-guided cryobiopsy for the diagnosis of ground-glass opacity-predominant peripheral pulmonary nodules.Respiratory research · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
50 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Shape-sensing robotic-assisted bronchoscopy (ssRAB) is a new bronchoscopy technology that utilizes optic fibers to provide accurate position information and robotic-control to deliver improved maneuverability. This technology has been used in the United States since 2019 and investigated in China since 2021. In order to provide a standard practice and make the best use of this technology for managing peripheral pulmonary lesions (PPLs), experts developed the consensus. Methods: This consensus was developed using Delphi method. A panel comprising nine experts formulated eight consensus statements after a thorough review of clinical evidence and practical experience. During the second phase, a questionnaire was distributed to collect feedback on these statements from an external panel of 39 physicians. The percentage of responses and the percentage of agreement on each statement were calculated. The consensus was defined as achieved with an agreement percentage threshold of 80% or above. Results: The eight consensus statements formulated in phase 1 included recommendations for path planning, anesthesia, the use of radial endobronchial ultrasound (EBUS), the use of fluoroscopy and/or cone-beam computed tomography (CBCT) with ssRAB, solving computed tomography (CT)-to-body divergence, the use of sampling tools with ssRAB, cloud biopsy, and the use of rapid on-site evaluation (ROSE) with ssRAB. All panel physicians completed the questionnaire in phase 2. All the statements achieved positive consensus, with six receiving 100% agreement and two reaching 97.4% agreement. Conclusions: The document establishes a consensus on recommended practices for optimal utilization of ssRAB technology in the management of PPLs. The guidelines will be updated as new evidence emerges or additional ssRAB platforms are introduced into practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.